“Venture capitalists in Michigan continue to grow in an environment where, in other parts of the country, the industry is contracting,” said a Managing Director of Arboretum Ventures and the outgoing chair of the Michigan Venture Capital Association.
NeuMoDx Molecular, Inc. announced completion of its Series B financing, $21 million, which included investment from Baird Capital, Venture Investors, and existing investor Arboretum Ventures.